Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for liver function protection after laparoscopic colorectal cancer surgery
ChiCTR1800019149Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in hepatic disease (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Alanine aminotransferase. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ChiCTR1800019149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019149.